Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer

Update Il y a 4 ans
Reference: NCT01880385

Woman Man

  • | Country :
  • Tunisia
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Multi-center, non randomised, open label, non controlled pilot study. Evaluating the treatment of bevacizumab in association with pre-operative chemotherapy, followed by surgery, adjuvant chemotherapy and radiotherapy in Patients with inflammatory breast cancer.


Inclusion criteria

  • Inflammatory Breast Cancer

Links